Publications
- The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers2015 | First Faculty of Medicine
- Biological therapy of inflammatory autoimmune disease in rheumatology, gastroenterology and dermatology2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: A EULAR extension of STROBE guidelines based on experience from biologics registries2014 | First Faculty of Medicine
- New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis2023 | First Faculty of Medicine, Second Faculty of Medicine
- Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease2023 | First Faculty of Medicine, Faculty of Science
- Interleukin-37: associations of plasma levels and genetic variants in gout2023 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson’s disease2023 | First Faculty of Medicine, Faculty of Science
- Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe2023 | First Faculty of Medicine
- What's new in rheumatology2023 | First Faculty of Medicine
- Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching2023 | First Faculty of Medicine
Loading network view...